Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
Go back to Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device(NASDAQ: NMRD) | Delayed: 0.11 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.11 | 52 Week High | $2.10 | |||
Open | $0.11 | 52 Week Low | $0.25 | |||
Day High | $0.11 | P/E | N/A | |||
Day Low | $0.11 | EPS | $0.00 | |||
Volume | 103 |